Evidence map›Paper›PMID 37756395›Full record

ArticleScience advances2023

Cell state transition analysis identifies interventions that improve control of

Shivraj M Yabaji, Oleksii S Rukhlenko, Sujoy Chatterjee, Bidisha Bhattacharya, Emily Wood, Marina Kasaikina, Boris N Kholodenko, Alexander A Gimelbrant, Igor Kramnik

Abstract read
In one paragraph

Article in Science advances, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Lung epithelial injury impairs early host immune responses to Mycobacterium tuberculosis.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Shivraj M YabajiThe National Emerging Infectious Diseases Laboratories (NEIDL), Boston University, Boston, MA, USA.ORCID 0000-0002-5793-1661
Oleksii S RukhlenkoSystems Biology Ireland, School of Medicine and Medical Science, University College Dublin, Belfield Dublin 4, Ireland.ORCID 0000-0003-1863-4987
Sujoy ChatterjeeThe National Emerging Infectious Diseases Laboratories (NEIDL), Boston University, Boston, MA, USA.
Bidisha BhattacharyaThe National Emerging Infectious Diseases Laboratories (NEIDL), Boston University, Boston, MA, USA.
Emily WoodSystems Biology Ireland, School of Medicine and Medical Science, University College Dublin, Belfield Dublin 4, Ireland.
Marina KasaikinaThe National Emerging Infectious Diseases Laboratories (NEIDL), Boston University, Boston, MA, USA.
Boris N KholodenkoSystems Biology Ireland, School of Medicine and Medical Science, University College Dublin, Belfield Dublin 4, Ireland.ORCID 0000-0002-9483-4975
Alexander A GimelbrantAltius Institute for Biomedical Sciences, Seattle, WA, USA.ORCID 0000-0001-6986-0285
Igor KramnikThe National Emerging Infectious Diseases Laboratories (NEIDL), Boston University, Boston, MA, USA.ORCID 0000-0001-6511-9246

Funding

Necrosis in pulmonary TB granulomas: dynamics, mechanisms, therapiesR01HL126066 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI KRAMNIK, IGOR, NIEDERWEIS, MICHAEL · 2016 to 2025
$5.6M
Mechanism and function of autosomal analog of X inactivationR01GM114864 · NIGMS · DANA-FARBER CANCER INST · PI GIMELBRANT, ALEXANDER · 2014 to 2018
$4.9M
Multiscale Modeling to Optimize Inhibition of Oncogenic ERK Pathway SignalingR01CA244660 · NCI · YALE UNIVERSITY · PI HLAVACEK, WILLIAM S, KHOLODENKO, BORIS N · 2020 to 2024
$3.4M
Toxin secretion and trafficking by Mycobacterium tuberculosisR01AI175106 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI MICHAEL NIEDERWEIS · 2023 to 2026
$3.0M
NCI NIH HHS R01 CA244660NHLBI NIH HHS R01 HL126066NIAID NIH HHS R01 AI175106NIGMS NIH HHS R01 GM114864
6 · The paper itself

Abstract

Understanding cell state transitions and purposefully controlling them to improve therapies is a longstanding challenge in biological research and medicine. Here, we identify a transcriptional signature that distinguishes activated macrophages from the tuberculosis (TB) susceptible and resistant mice. We then apply the cSTAR (cell state transition assessment and regulation) approach to data from screening-by-RNA sequencing to identify chemical perturbations that shift the transcriptional state of tumor necrosis factor (TNF)-activated TB-susceptible macrophages toward that of TB-resistant cells, i.e., prevents their aberrant activation without suppressing beneficial TNF responses. Last, we demonstrate that the compounds identified with this approach enhance the resistance of the TB-susceptible mouse macrophages to virulent

Indexed as

Mycobacterium tuberculosisTuberculosisAnimalsDisease SusceptibilityMacrophagesMiceTumor Necrosis Factor-alphaTumor Necrosis Factor-alpha

Identifiers

PMID37756395
PMCPMC10530096

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.